Metoperil Injection containing Metoprolol Tartrate is used for the management of cardiac conditions and hypertension. It helps in controlling heart rate and reducing strain on the heart.
Metoprolol Tartrate works as a beta-blocker by slowing the heart rate and reducing the force of heart contractions, which helps improve cardiac efficiency and lower blood pressure.
The injection is widely used in hospitals and emergency care settings for cardiac management, leading to consistent demand in institutional healthcare segments.
With increasing prevalence of cardiovascular disorders and growing demand for emergency cardiac care medicines, this product offers strong business potential for distributors and institutional suppliers. Its essential role in hospital care, steady clinical demand, and broad cardiac application make it a reliable product for consistent sales and growth in the cardiac segment.
Some patients may experience dizziness, low blood pressure, slow heart rate, fatigue, or nausea. Rarely, bronchospasm, severe bradycardia, or worsening heart failure symptoms may occur and require immediate medical attention.
Metoperil Injection is indicated for the management of acute myocardial infarction, tachyarrhythmias, hypertension, and other cardiac conditions requiring rapid beta-blocker therapy. It helps control heart rate, reduce chest pain, stabilize cardiac rhythm, and decrease cardiac stress.
This injection should be administered under strict medical supervision with monitoring of heart rate and blood pressure. Use cautiously in patients with asthma, diabetes, heart block, or severe heart failure. Sudden withdrawal should be avoided.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.